Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-02

Clinical Trial Update: Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD [Phase 2]

View source ↗

Summary

Phase 2 exploratory fMRI trial in children with ADHD investigating a treatment for impulsive aggression; the study was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Impulsive Aggression | Phase 2 | Status: TERMINATED | Results posted: 2025-05-02